Core Laboratories (NYSE:CLB) Announces Earnings Results

Core Laboratories (NYSE:CLB) posted its earnings results on Wednesday. The oil and gas company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.03, FiscalAI reports. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. Core Laboratories’s quarterly revenue was down 4.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.19 EPS. Core Laboratories updated its Q3 2026 guidance to 0.120-0.200 EPS.

Core Laboratories Stock Down 7.7%

Shares of NYSE CLB traded down $0.82 during midday trading on Wednesday, hitting $9.87. The company’s stock had a trading volume of 1,604,259 shares, compared to its average volume of 590,079. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.05 and a quick ratio of 1.50. The firm has a market capitalization of $454.75 million, a price-to-earnings ratio of 15.18, a price-to-earnings-growth ratio of 2.71 and a beta of 1.00. The business’s fifty day simple moving average is $12.24 and its two-hundred day simple moving average is $15.38. Core Laboratories has a 1 year low of $9.72 and a 1 year high of $20.36.

Institutional Investors Weigh In On Core Laboratories

Hedge funds have recently added to or reduced their stakes in the business. Aster Capital Management DIFC Ltd acquired a new position in shares of Core Laboratories in the fourth quarter worth $34,000. Quarry LP boosted its holdings in Core Laboratories by 118.1% in the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after purchasing an additional 1,599 shares during the period. Tower Research Capital LLC TRC boosted its holdings in Core Laboratories by 400.9% in the second quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock valued at $84,000 after purchasing an additional 5,869 shares during the period. Vestcor Inc purchased a new stake in Core Laboratories during the 3rd quarter worth about $101,000. Finally, Mercer Global Advisors Inc. ADV purchased a new stake in Core Laboratories during the 3rd quarter worth about $132,000. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on CLB shares. Wall Street Zen downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. Weiss Ratings downgraded shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce”.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.